Test ID: F5DNA
Factor V Leiden (R506Q) Mutation, Blood
Secondary ID 
A test code used for billing and in test definitions created prior to November 2011
81419
Useful For Suggests clinical disorders or settings where the test may be helpful
Direct mutation analysis should be reserved for patients with clinically-suspected thrombophilia and:
-APC-resistance proven or suspected by a low APC-resistance ratio
-Family history of the factor V (FV Leiden) mutation
Additionally, it may be appropriate to screen those women contemplating oral contraceptive use or pregnancy, with consideration of an alternative form of contraceptive therapy or venous thromboembolism (VTE) prophylaxis during pregnancy and/or the post-partum state for women with FV Leiden allele.
Knowledge of the FV Leiden allele status may alter anticoagulation management of VTE patients.
Genetics Test Information Provides information that may help with selection of the correct test or proper submission of the test request
Tests for R506Q mutation only.
Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test
Method Name A short description of the method used to perform the test
Direct Mutation Analysis
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
Factor V Leiden (R506Q) Mutation, B
Aliases Lists additional common names for a test, as an aid in searching
Activated protein C (APC) resistance mutation
APC resistance mutation
Factor V Leiden mutation
APC resistance mutation
Factor V Leiden mutation
External
link
PDF
document
Excel
document
Word
document